| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |